In this article, we will take a look at the 5 Best Hemp Stocks To Buy Now. For a deeper discussion and an extended list, please see the 7 Best Hemp Stocks To Buy Now.
kostrez/Shutterstock.com
5. Turning Point Brands, Inc. (NYSE:TPB)
On April 23, Alliance Global dropped its price target for Turning Point Brands, Inc. (NYSE:TPB) to $130 from $135. It maintained a Buy rating on the stock. The firm added that it cut forecasts ahead of the first quarter to reflect expected softness in legacy industries and expenditures in nicotine pouches weighing on profits.
Earlier, on March 3, Alliance Global analyst Aaron Grey boosted the target for Turning Point Brands, Inc. (NYSE:TPB) to $135 from $110 after Q4. It retained a Buy rating. The firm expected that 2026 would be a “healthy sales growth year,” although cautioning that higher trade spending adds uncertainty to net sales projections.
The firm also sees Turning Point Brands, Inc. (NYSE:TPB) as a possible “winner within the modern oral pouch category.”
Turning Point Brands, Inc. (NYSE:TPB)’ 2026 outlook expects Modern Oral gross revenue of $220 million to $240 million and net revenue of $180 million to $190 million. The first-quarter adjusted EBITDA is expected to be between $24 million and $27 million, including investments in sales, marketing, and trade promotions.
Turning Point Brands, Inc. (NYSE:TPB) manufactures, markets, and distributes branded consumer items, including alternative smoking accessories and consumables containing active substances. It functions through Zig-Zag Products, Stoker’s Products, and Creative Distribution Solutions segments.
4. SNDL Inc. (NASDAQ:SNDL)
On April 29, 2026, SNDL Inc. (NASDAQ:SNDL) reported its first-quarter 2026 results. It had net revenue of $195.9 million with a 4.4% year-over-year drop because of market issues in the liquor and cannabis areas. The company posted a gross profit of $52.8 million, down 6.8%, with a gross margin of 27.0%, down 0.7 percentage points. This was because of Cannabis Operations.
SNDL Inc. (NASDAQ:SNDL) reported an operating loss of $9.1 million, up by $2.9 million from the previous year. It reflected the lack of prior value reductions and restructuring expenses. Cash flow stayed negative at $26.7 million, with free cash flow at negative $7.6 million, because of inventory buildups and income statement losses.
CEO Zach George said that the market downturn made the quarter “particularly challenging,” and noted persistent cost changes. The firm repurchased 4.5 million shares and concluded the quarter with $213.4 million in unrestricted cash and no debt, preparing for capital deployment.
SNDL Inc. (NASDAQ:SNDL) is a licensed producer that makes limited cannabis in advanced indoor facilities. It operates in liquor retail, cannabis retail, cannabis operations, and investments segments.
3. High Tide Inc. (NASDAQ:HITI)
On April 20, 2026, High Tide Inc. (NASDAQ:HITI) announced that its Canna Cabana store in Caledonia, Ontario, will start adult-use cannabis sales, lifting its network to 221 sites countrywide and 97 in Ontario.
As per the company’s outlook, Canna Cabana handles 220 locations, and it is looking forward to adding 20-30 more in 2026. It has a long-term goal of topping 350 sites, besides looking into M&A prospects. It stated that its white-label portfolio has grown to 35 SKUs, accounting for 1.6% of retail sales, with plans to expand to about 20% over time.
High Tide Inc. (NASDAQ:HITI) said that Cabana Club membership in Canada surpassed 2.58 million, a 47% growth YoY, while global membership reached 6.65 million, with ELITE members exceeding 171,000 worldwide.
The company stated that its e-commerce unit contributed 2% of revenue and had recovered sequentially. Remexian pulled off $25 million in Q1 sales, up over 70% sequentially, with February revenue exceeding $12 million.
High Tide Inc. (NASDAQ:HITI) is a retail cannabis firm. It manufactures and distributes consumer accessories. It operates in three brick-and-mortar, e-commerce, and medical cannabis distribution segments.
2. Canopy Growth Corporation (NASDAQ:CGC)
On April 23, 2026, Canopy Growth Corporation (NASDAQ:CGC) announced a refresh of its Tweed cannabis brand. They are starting a nationwide summer promotion called “There’s a Tweed for That.” This promotion includes window bags, improved potency, and lower cost. The update gives consumers visibility into flower products while also addressing demand for accessible formats.
According to CEO Luc Mongeau, the revamp includes consumer and merchant feedback, “improved potency, sharpened pricing,” and a cleaner product presentation.
Earlier, on March 31, 2026, Canopy Growth Corporation (NASDAQ:CGC) debuted Deelish, a cannabis brand. This brand offers flower products with 27%-33% THC and pre-rolls with 26%-32% THC. Deelish rotates genetic offerings to supply cultivars throughout time, with a focus on daily consumers, it noted.
Mongeau said that the value market remains active, and Deelish is looking to provide “high-potency product at a price that respects how they shop.”
Canopy Growth Corporation (NASDAQ:CGC) produces, sells, and distributes cannabis and products derived from cannabinoids for both medical and recreational use. The company works in Canada Cannabis, International Markets Cannabis, Storz and Bickel, This Works, and Other areas.
1. Tilray Brands, Inc. (NASDAQ:TLRY)
On April 22, Bloomberg reported, citing an on-air discussion with CEO Irwin Simon, that Tilray Brands, Inc. (NASDAQ:TLRY) shares rose by around 10% after surging as much as 18% earlier, amid strong trading activity of more than 20 million shares. He said the move shows interest in a potential cannabis reclassification, stressing that it is important “for patients” and the larger business, not just the corporation. He noted that the corporation distributes cannabis in over 21 countries, producing more than $100 million globally and $200 million in Canada, as well as conducts research into medical applications such as cancer and epilepsy.
As per the CEO, Tilray Brands, Inc. (NASDAQ:TLRY) does not currently sell cannabis in the United States, explaining that the company has instead grown into beer and beverages. He said that reclassification would help collaboration with the FDA, using current research for approvals addressing medical conditions. Entering the US market could happen “within six months” if licenses are granted, he said, calling the prospect “tremendous” given the firm’s infrastructure and global experience.
Tilray Brands, Inc. (NASDAQ:TLRY) is a consumer packaged goods firm. It focuses on medical cannabis research and the cultivation, processing, and global distribution of cannabis products. It operates in the cannabis, distribution, beverage, and wellness segments.
While we acknowledge the potential of TLRY to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than TLRY and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: 20 Best Performing Stocks in 2025 and 12 Best Food Stocks to Buy in 2026.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
